SCHEMBL3028813

SCHEMBL3028813

CC(Cl)OCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287173 0.79
SCHEMBL4219834 0.77
SCHEMBL16166922 0.77
SCHEMBL21633906 0.77
SCHEMBL11232332 0.77
SCHEMBL19225690 0.75
SCHEMBL11658193 0.73 GABRR1 (0.34)
Hydrochloric Acid SCHEMBL31482565 0.73 EPHX1 (0.31)
SCHEMBL15808491 0.73
SCHEMBL7052237 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100210864-A1 PROCESS FOR THE PREPARATION OF N-ARYLMORPHOLINONES DORSCH DIETER 2010-08-19 US disclosed
US-7687624-B2 Process for the production of N-arylmorpholinones MERCK PATENT GMBH (DE) 2010-03-30 US disclosed
US-20060217550-A1 One pot process; cyclization; 4-(4-nitrophenyl)-3-oxomorpholine; Factor Xa inhibitors; , myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and claudicatio intermittens MERCK PATENT GMBH (DE) 2006-09-28 US disclosed